Form 4: Bio-Key International Director Acquires Shares in Lieu of Board Fees

Emmanuel Alia, a director at Bio-Key International, acquired 3,897 shares of common stock on May 8, 2025, as payment for board meeting attendance fees.

Summary

• On May 8, 2025, Emmanuel Alia, a director of Bio-Key International, acquired 3,897 shares of common stock.
• The shares were issued under the company's 2023 Stock Incentive Plan.
• The acquisition was in payment of board meeting attendance fees.
• Following the transaction, Alia directly owns 16,323 shares of Bio-Key International.
• This transaction was reported in a Form 4 filing with the SEC on May 12, 2025.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction related to director compensation. It shows alignment of interests but doesn't indicate significant positive or negative news.

Positives

• The acquisition of shares by a director demonstrates their continued investment in the company's success.
• Using the stock incentive plan to pay board fees conserves cash for the company.

Industry Context

Directors receiving stock in lieu of cash compensation is a fairly common practice, especially for smaller companies, as it helps preserve cash and aligns the interests of the directors with those of the shareholders.

Related Party Transactions

• The issuance of shares to Emmanuel Alia, a director, in payment of board meeting attendance fees is a related party transaction.

Stakeholder Impact

• Shareholders may view this positively as it aligns director interests with company performance and conserves cash.
• Employees are not directly impacted by this transaction.

Key Dates

Keywords

Form 4, BIO-KEY INTERNATIONAL, BKYI, Director, Share Acquisition, Stock Incentive Plan, Emmanuel Alia, Beneficial Ownership